Atjaunināt sīkdatņu piekrišanu

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future 2013 ed. [Hardback]

Edited by
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 136,16 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 160,19 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future 2013 ed.Palielināt
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9789400758650.html
Keywords:

This book will compile a collection of chapters dedicated to varied aspects of PPPM in neuropsychiatric and neurodegenerative diseases. Among the topics to be covered are:
Recent advances in ALS research
News about Clinical aspects and advanced therapy approaches in personalized treatment of ALS Schizophrenia: New treatments and clinical aspects
Predictive, Preventive and Personalised Medicine in aging macular degeneration
Advances in Multiple Sclerosis Pharmacogenetics, Tailoring Treatment Efficacy, Safety and Regimen Selection
Multiple sclerosis related biomarkers: perspectives for clinical application
Preventive clinical trials in brain aging: new trends & the need of guidelines
MCI_ clinical guidelines in early diagnosis of dementia
Alzheimer's disease: diagnostics, prognostics and the road to prevention
Biomarkers for early diagnosis of Parkinson's and Alzheimer's diseases
Synucleinopathies, tauopathies, TDP-43 proteinopathies and amyloidosis PSP, MSA and other parkinsonisms

Recenzijas

From the reviews:

This book provides an overview of up-to-date literature on existing and potential future predictive, preventive, and personalized therapeutic approaches to neurodegenerative diseases. It is a useful resource for clinicians and researchers interested in the current status of research findings and their potential future applications in this field. (Nilufer Ertekin-Taner, Doodys Book Reviews, October, 2013)

Part I
Time for New Guidelines in Handling of Neurodegenerative Disorders: Optimistic Versus Pessimistic Prognosis by Application of PPPM
3(10)
Silvia Mandel
Olga Golubnitschaja
Part II
Individual Predispositions in Healthy Vasospastic Individuals: Patient Profiling for Targeted Prevention of "Down-Stream" Pathologies as Cost-Effective Personalised Medicine
13(18)
Kristina Yeghiazaryan
Josef Flammer
Olga Golubnitschaja
Idiopathic REM Sleep Behavior Disorder as a Long-Term Predictor of Neurodegenerative Disorders
31(14)
Stephany Fulda
Mauro Manconi
New Animal Models of Progressive Neurodegeneration: Tools for Developing Predictive Diagnostics and Identifying Presymptomatic Therapeutic Targets
45(24)
Amber L. Marriott
Daphne A. Gill
Christopher A. Shaw
R. Andrew Tasker
Tau Pathology: A Selected View on the Current Status
69(26)
Illana Gozes
Part III
The Use of Biomarkers for Prediction and Prevention of Alzheimer's and Parkinson's Diseases
95(46)
Silvia Mandel
Amos D. Korczyn
Clinical Trials of AD Delay of Onset: Enrichment by a Prognostic Genetic Biomarker
141(20)
Iris Grossman
Michael W. Lutz
Donna G. Crenshaw
Ann M. Saunders
Ornit Chiba-Falek
William K. Gottschalk
Allen D. Roses
An Update on CSF Biomarkers of Parkinson's Disease
161(26)
Peter A. LeWitt
Bertrand R. Huber
Jing Zhang
Part IV
Glaucomatous Optic Neuropathy: Risk Assessment and Potential Targets for Effective Prevention and Treatments Tailored to the Patient
187(18)
Olga Golubnitschaja
Kristina Yeghiazaryan
Josef Flammer
Part V
Toward a Personalized Approach in Amyotrophic Lateral Sclerosis: New Developments in Diagnosis, Genetics, Pathogenesis and Therapies
205(30)
Beatrice Nefussy
Vivian E. Drory
Recent Advances in ALS Research: Perspectives for Personalized Clinical Application
235(42)
Chen Benkler
Daniel Offen
Eldad Melamed
Tamar Amit
Silvia Mandel
Moussa B.H. Youdim
Orly Weinreb
Part VI
Exercise in Multiple Sclerosis - An Integral Component of Disease Management
277(24)
Andrea Doring
Caspar F. Pfueller
Friedemann Paul
Jan Dorr
Bridging the Informatics Gap Between Bench and Bedside: Implications to Neurodegenerative Diseases
301(10)
Amnon Shabo (Shvo)
Maurizio Scarpa
Part VII
Personalized Medicine in Rare Pediatric Neurometabolic Diseases
311(18)
Rosella Tomanin
Cinzia Maria Bellettato
Francesca D'Avanzo
Alessandra Zanetti
Adriana Ceci
David Begley
Maurizio Scarpa
Author Index 329(60)
Subject Index 389